EV/EBITDA Ratio: 30.68x

Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 30.68x is 76% below its 2-year average of 125.84x, near the low end of its 2-year range (26.53x–243.24x).

As of Friday, August 28, 2026. 68.16% below its 12-month average of 96.36x.

ALNY EV/EBITDA Ratio Metrics

EV/EBITDA vs. its own history

At 30.7, EV/EBITDA is below its 2-year median — higher than 7% of readings in its 2-year history.

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Alnylam Pharmaceuticals, Inc. (ALNY)?

The EV/EBITDA ratio for ALNY stock is 30.68x.

Is Alnylam Pharmaceuticals, Inc.'s EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 30.68x is 76% below its 2-year average of 125.84x, near the low end of its 2-year range (26.53x–243.24x).

What is the TTM average EV/EBITDA ratio for Alnylam Pharmaceuticals, Inc. (ALNY)?

The TTM average EV/EBITDA ratio for ALNY stock is 96.36x.

Showing the most recent 260 of 272 data points. The chart above shows the full history.

Related Metrics